Global Equine Pharmaceuticals and Supplements Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

The Equine Pharmaceuticals and Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Equine Pharmaceuticals and Supplements market size is estimated to be worth US$ 1181.2 million in 2021 and is forecast to a readjusted size of USD 1586.8 million by 2028 with a CAGR of 4.3% during review period. Thoroughbred Horse accounting for % of the Equine Pharmaceuticals and Supplements global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pharmaceuticals segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Equine Pharmaceuticals and Supplements include Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, and Elanco Animal Health, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Equine Pharmaceuticals and Supplements market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Pharmaceuticals
    Supplements
Market segment by Application can be divided into
    Thoroughbred Horse
    Other Types of Horses
The key market players for global Equine Pharmaceuticals and Supplements market are listed below:
    Boehringer Ingelheim
    Merck Animal Health
    Zoetis
    Bayer Animal Health
    Elanco Animal Health
    Dechra Veterinary Products
    CEVA
    Virbac
    Norbrook Equine
    Kyoritsu Seiyaku
    Vetoquinol
    Protexin Healthcare
    Audevard
    Ouro Fino Saude
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Pharmaceuticals and Supplements product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Pharmaceuticals and Supplements, with price, sales, revenue and global market share of Equine Pharmaceuticals and Supplements from 2019 to 2022.
Chapter 3, the Equine Pharmaceuticals and Supplements competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Pharmaceuticals and Supplements breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Equine Pharmaceuticals and Supplements.
Chapter 13, 14, and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, customers, research findings and conclusion, appendix and data source.